Context:
        The optimal ischemia technique at partial nephrectomy (PN) for renal masses is yet to be determined.
      
          
        Objective:
        To summarize and analyze the current evidence about surgical, oncological, and functional outcomes after different ischemia techniques (cold, warm, and zero ischemia) at PN.
      
          
        Evidence Acquisition:
        A computerized systematic literature search was performed by using PubMed (MEDLINE) and Science Direct. Identification and selection of the studies were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria. Outcomes of interest were estimated blood loss (EBL), overall complications, positive surgical margins, local tumor recurrence, and renal function preservation. Meta-analysis and forest-plot diagrams were performed. Overall pooled estimates, together with 95% confidence intervals (CIs), of the incidence of all parameters were obtained using a random effect model (RE-Model) on the log transformed means (MLN), proportion, or standardized mean change, as deemed appropriate.
      
          
        Evidence Synthesis:
        One hundred and fifty-six studies were included. No clinically meaningful differences were found in terms of EBL after cold (mean: 215.5; 95% CI: 154.2-276.8m), warm (mean: 201.8; 95% CI: 175.0-228.7ml), or zero (mean: 261.2; 95% CI: 171.0-351.3ml) ischemia technique. Overall, postoperative complications were recorded in 14.1% (95% CI: 6.7-27.4), 11.1% (95% CI: 10.0-12.3), and 9.7% (95% CI: 7.7-12.2) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Positive surgical margins were recorded in 4.8% (95% CI: 1.9-10.9), 4.0% (95% CI: 3.4-4.8), and 5.6% (95% CI: 3.1-9.8) of patients after cold, warm, and zero ischemia (p<0.01), respectively. Local recurrence was recorded in 3.2% (95% CI: 1.9-5.2) and 3.1% (95% CI: 0.7-11.5) of patients after warm and zero ischemia (p<0.01), respectively. The log of estimated glomerular filtration ratio mean changes were-1.37 (95% CI:-3.42 to 0.68),-1.00 (-2.04 to 0.03), and-0.71 (-1.15 to-0.27) ml/min after cold, warm, and zero ischemia, respectively. Low level of evidence, retrospective nature of most of included studies, a high risk of selection bias, and heterogeneity within included studies limited the overall quality of the analysis.
      
          
        Conclusions:
        The effect of ischemia technique at PN is still debatable and subject to confounding by several factors, namely, patients' selection criteria, surgical technique used, and percentage of functional parenchyma spared during surgery. These confounders bias available evidence and were addressed by only a small part of available studies. Unfortunately, the overall quality of literature evidences and the high risk of selection bias limit the possibility of any causal interpretation about the relationship between the ischemia technique used and surgical, oncological, or functional outcomes. Thus, none of the available ischemia technique could be recommended over the other.
      
          
        Patient Summary:
        The present analysis shows that none of the available ischemia techniques, namely, cold, warm, or zero ischemia, is universally superior to the others, and other factors play a role in the surgical outcome.
      
       
          
          
                      
              
  Citing Articles
                              
  Does the transfer of knowledge from the pioneer generation to the second-generation speed-up the learning curve of robot-assisted partial nephrectomies? TRANSFER trial (UroCCR n°83).
  
    Vignot L, Khene Z, Mellouki A, Morrone A, Bernhard J, Bensalah K
    
    
    BJUI Compass. 2025; 6(1):e477.
  
  
    PMID: 39877566
    
          PMC: 11772077.
    
          DOI: 10.1002/bco2.477.
      
 
                                  
                                              
  Tracing the evolving dynamics and research hotspots in the kidney neoplasm and nephron sparing surgery field from the past to the new era.
  
    Yao Y, Liu Y, Yang T, Lu B, Yang X, Zhang H
    
    
    Cancer Med. 2024; 13(12):e7336.
  
  
    PMID: 39651783
    
          PMC: 11192648.
    
          DOI: 10.1002/cam4.7336.
      
 
                                  
                                              
  On-clamp vs off-clamp robot-assisted partial nephrectomy for achieving modified trifecta: inverse probability of treatment weighting analysis from a high-volume tertiary robotic center.
  
    Belmonte M, Frego N, Ticonosco M, Pissavini A, Balestrazzi E, Sorce G
    
    
    J Robot Surg. 2024; 18(1):327.
  
  
    PMID: 39167125
    
    
          DOI: 10.1007/s11701-024-02078-3.
      
 
                                  
                                              
  Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique.
  
    Franco A, Riolo S, Tema G, Guidotti A, Brassetti A, Anceschi U
    
    
    Diagnostics (Basel). 2024; 14(15).
  
  
    PMID: 39125455
    
          PMC: 11311424.
    
          DOI: 10.3390/diagnostics14151579.
      
 
                                  
                                              
  The evolving management of small renal masses.
  
    Wang Y, Butaney M, Wilder S, Ghani K, Rogers C, Lane B
    
    
    Nat Rev Urol. 2024; 21(7):406-421.
  
  
    PMID: 38365895
    
    
          DOI: 10.1038/s41585-023-00848-6.
      
 
                              
              
                              
                
                
                                      
  The Association of Ischemia Type and Duration with Acute Kidney Injury after Robot-Assisted Partial Nephrectomy.
  
    Obrecht F, Padevit C, Froelicher G, Rauch S, Randazzo M, Shariat S
    
    
    Curr Oncol. 2023; 30(11):9634-9646.
  
  
    PMID: 37999118
    
          PMC: 10670720.
    
          DOI: 10.3390/curroncol30110698.
      
 
                                          
                                                          
  Technologic advances in robot-assisted nephron sparing surgery: a narrative review.
  
    Thakker P, ORourke Jr T, Hemal A
    
    
    Transl Androl Urol. 2023; 12(7):1184-1198.
  
  
    PMID: 37554533
    
          PMC: 10406549.
    
          DOI: 10.21037/tau-23-107.
      
 
                                          
                                                          
  Endovascular management of RCC in one-kidney patient: a case report study.
  
    Ghareeb A, Salameh B, Halaweh M, Al-Tawil M, Nahas M
    
    
    Ann Med Surg (Lond). 2023; 85(5):2108-2111.
  
  
    PMID: 37229010
    
          PMC: 10205279.
    
          DOI: 10.1097/MS9.0000000000000559.
      
 
                                          
                                                          
  Robotic versus Laparoscopic Partial Nephrectomy in the New Era: Systematic Review.
  
    Ruiz Guerrero E, Claro A, Ledo Cepero M, Soto Delgado M, Alvarez-Ossorio Fernandez J
    
    
    Cancers (Basel). 2023; 15(6).
  
  
    PMID: 36980679
    
          PMC: 10046669.
    
          DOI: 10.3390/cancers15061793.
      
 
                                          
                                                          
  Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans.
  
    Rothner A, Gov T, Hinden L, Nemirovski A, Tam J, Rosenzweig B
    
    
    Int J Mol Sci. 2023; 24(4).
  
  
    PMID: 36835635
    
          PMC: 9962891.
    
          DOI: 10.3390/ijms24044216.
      
 
                                          
                                                          
  Every decade counts: a narrative review of functional recovery after partial nephrectomy.
  
    Campbell S, Campbell J, Munoz-Lopez C, Rathi N, Yasuda Y, Attawettayanon W
    
    
    BJU Int. 2022; 131(2):165-172.
  
  
    PMID: 35835519
    
          PMC: 10087004.
    
          DOI: 10.1111/bju.15848.
      
 
                                          
                                                          
  Changes in kidney function according to ischemia type during partial nephrectomy for T1a kidney cancer.
  
    Lee J, Hwang Y, Yoo S, Choo M, Cho M, Son H
    
    
    Sci Rep. 2022; 12(1):4223.
  
  
    PMID: 35273257
    
          PMC: 8913619.
    
          DOI: 10.1038/s41598-022-07919-5.
      
 
                                          
                                                          
  Zero ischemia laparoscopic microwave ablation assisted enucleation  laparoscopic partial nephrectomy in clinical T1a renal tumor: a randomized clinical trial.
  
    Wu X, Chen W, Huang J, Zhang J, Liu D, Huang Y
    
    
    Transl Cancer Res. 2022; 9(1):194-202.
  
  
    PMID: 35117173
    
          PMC: 8798795.
    
          DOI: 10.21037/tcr.2019.12.73.
      
 
                                          
                                                          
  Robotic-Assisted Partial Nephrectomy: Techniques to Improve Clinical Outcomes.
  
    Macek P, Cathelineau X, Barbe Y, Sanchez-Salas R, Rodriguez A
    
    
    Curr Urol Rep. 2021; 22(10):51.
  
  
    PMID: 34622373
    
    
          DOI: 10.1007/s11934-021-01068-4.
      
 
                                          
                                                          
  Comparison of Perioperative, Renal Functional, and Oncological Outcomes Between Off-Clamp and On-Clamp Robot-Assisted Partial Nephrectomy for Renal Tumors: An Updated Evidence-Based Analysis.
  
    Huang Y, Cao D, Chen Z, Chen B, Li J, Guo J
    
    
    Front Oncol. 2021; 11:730662.
  
  
    PMID: 34621676
    
          PMC: 8490928.
    
          DOI: 10.3389/fonc.2021.730662.
      
 
                                          
                                                          
  3D-Image guided robotic-assisted partial nephrectomy: a multi-institutional propensity score-matched analysis (UroCCR study 51).
  
    Michiels C, Khene Z, Prudhomme T, Boulenger de Hauteclocque A, Cornelis F, Percot M
    
    
    World J Urol. 2021; 41(2):303-313.
  
  
    PMID: 33811291
    
    
          DOI: 10.1007/s00345-021-03645-1.
      
 
                                          
                                                          
  Robotic renal and adrenal oncologic surgery: A contemporary review.
  
    Bhat K, Moschovas M, Onol F, Rogers T, Roof S, Patel V
    
    
    Asian J Urol. 2021; 8(1):89-99.
  
  
    PMID: 33569275
    
          PMC: 7859360.
    
          DOI: 10.1016/j.ajur.2020.05.010.
      
 
                                          
                                                          
  Role of minimally invasive partial nephrectomy in the management of renal mass.
  
    Lee R, Strauss D, Kutikov A
    
    
    Transl Androl Urol. 2021; 9(6):3140-3148.
  
  
    PMID: 33457286
    
          PMC: 7807341.
    
          DOI: 10.21037/tau.2019.12.24.
      
 
                                          
                                                          
  Renal function after partial nephrectomy following intra-arterial embolization of renal tumors.
  
    Brehier G, Bouvier A, Besnier L, Willoteaux S, Nedelcu C, Culty T
    
    
    Sci Rep. 2020; 10(1):21352.
  
  
    PMID: 33288819
    
          PMC: 7721888.
    
          DOI: 10.1038/s41598-020-78461-5.
      
 
                                          
                                                          
  Laparoscopic Versus Open Partial Nephrectomy: A Systemic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.
  
    You C, Du Y, Wang H, Peng L, Wei T, Zhang X
    
    
    Front Oncol. 2020; 10:583979.
  
  
    PMID: 33194725
    
          PMC: 7658533.
    
          DOI: 10.3389/fonc.2020.583979.